During the past decade, PMK Medical Group Inc conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "PMK Medical Group Inc" are "Colorectal Cancer" (2 trials) and "Non Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "PMK Medical Group Inc" in a lesser frequency.

Most popular intervention types in "PMK Medical Group Inc" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "oxaliplatin" (2 trials), "FOLFOX regimen" (1 trials), "IPI 504 plus Docetaxel" (1 trials), "Placebo plus Docetaxel" (1 trials) and "Taletrectinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "PMK Medical Group Inc" are 4 trials for "All" genders.

Currently, there are NaN active trials in "PMK Medical Group Inc". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in PMK Medical Group Inc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in PMK Medical Group Inc, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".